Skip to content

AYURVEDIC MANAGEMENT IN MADHUMEHA(PRAMEHA-DIABETIS)

Randomized controlled comparative clinical study to evaluate the efficacy of Gudmar Ghanvati with parijatak ghanvati in type-II Diabetes Mellitus w.s.t Prameha - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/089969
Enrollment
66
Registered
2025-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Sponsors

Dr SAGAR LAXMAN GAWALI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group in between 30 70 years 2. Patient of any gender,religion and socio-economic status. 3. Patient having signs and symptoms of prameha 4. HbA1C (6.5 to 9%) 5. Patients willing to participate with informed written consent.

Exclusion criteria

Exclusion criteria: 1. IDDM patients 2. Juvenile Diabetes, Acromegaly, Cushing s syndrome, pancreatic disorders. 3. Pregnancy, Unconscious patients. 4. Conditions like Cardiovascular disease, acute myocardial infarction, immune-compromised disease(HIV) 5. HbA1C less than 6.5% and greater than 9%

Design outcomes

Primary

MeasureTime frame
Does the Gudmar Ghanvati is effective in Prameha ?Timepoint: 90 days

Secondary

MeasureTime frame
To study the comparative effect of Gudmar Ghanvati & parijatak ghanvati on sign & symptoms of pramehaTimepoint: 90 days

Countries

India

Contacts

Public ContactDr. SAGAR LAXMAN GAWALI

ASS, Ayurvedic Mahavidyala Nashik

sanjivanirathod431@gmail.com8007229141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026